TC
AUPH icon

TwinBeech Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History

TwinBeech Capital’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$390K Buy
+26,300
New +$384K 0.04% 399
2025
Q4 		– Sell
-51,932
Closed -$574K – 591
2025
Q3 		$574K Buy
+51,932
New +$567K 0.02% 379
2024
Q1 		– Sell
-10,209
Closed -$91.8K – 549
2023
Q4 		$91.8K Sell
10,209
-135,136
-93% -$1.11M ﹤0.01% 608
2023
Q3 		$1.13M Buy
+145,345
New +$1.42M 0.02% 479
2022
Q3 		– Sell
-64,913
Closed -$652K – 620
2022
Q2 		$652K Buy
+64,913
New +$726K 0.03% 395
2022
Q1 		– Sell
-37,541
Closed -$859K – 496
2021
Q4 		$859K Buy
+37,541
New +$890K 0.05% 365

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return